4.7 Article

Preclinical Pharmacokinetics, Tissue Distribution and in vitro Metabolism of FHND6091, a Novel Oral Proteasome Inhibitor

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Medicinal

Whole blood or plasma: what is the ideal matrix for pharmacokinetic-driven drug candidate selection?

Ranjeet P Dash et al.

Summary: This article discusses the differences and influencing factors between using plasma and whole blood as matrices for quantifying drug concentrations in drug development. It ultimately points out the importance of determining the uptake of drugs into red blood cells when selecting drug candidates.

FUTURE MEDICINAL CHEMISTRY (2021)

Review Hematology

Current approaches to management of high-risk multiple myeloma

Sarah Goldman-Mazur et al.

Summary: The median overall survival for multiple myeloma patients is nearly 10 years, but a significant percentage still have poor prognosis. Therefore, individualized and intensive treatment approaches should be utilized, especially for high-risk patients. This includes using effective drug combinations, considering autologous stem cell transplantation, and maintenance based on proteasome inhibitor-based combinations.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Review Pharmacology & Pharmacy

Proteasome inhibitors for the treatment of multiple myeloma

Emilia Scalzulli et al.

EXPERT OPINION ON PHARMACOTHERAPY (2018)

Review Hematology

How is patient care for multiple myeloma advancing?

Sonja Genadieva Stavric et al.

EXPERT REVIEW OF HEMATOLOGY (2017)

Article Oncology

A phase I/II study of carfilzomib 2-10-min infusion in patients with advanced solid tumors

Kyriakos P. Papadopoulos et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)

Review Biochemistry & Molecular Biology

The 26S proteasome complex: An attractive target for cancer therapy

Sarah Frankland-Searby et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)

Article Medicine, Research & Experimental

Functional 20S proteasomes in mature human red blood cells

Sudha Neelam et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2011)

Article Chemistry, Analytical

Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method

Zhen Yang et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)

Review Hematology

Multiple myeloma

Robert A. Kyle et al.

Review Oncology

Ubiquitin ligases: cell-cycle control and cancer

KI Nakayama et al.

NATURE REVIEWS CANCER (2006)

Article Biochemical Research Methods

The human erythrocyte proteome - Analysis by ion trap mass spectrometry

DG Kakhniashvili et al.

MOLECULAR & CELLULAR PROTEOMICS (2004)

Review Oncology

The proteasome, a new target for cancer therapy

S Gillessen et al.

ONKOLOGIE (2002)